Education
About Us
Working with TipRanks
Follow Us
Venus Remedies Limited (IN:VENUSREM)
:VENUSREM
Total Valuation
Venus Remedies Limited has a market cap or net worth of ₹4.50B. The enterprise value is ₹3.58B.
Market Cap₹4.50B
Enterprise Value₹3.58B
Share Statistics
Venus Remedies Limited has 13,366,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,366,988
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Venus Remedies Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Venus Remedies Limited is ―. Venus Remedies Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Venus Remedies Limited had revenue of 5.91B and earned 284.91M in profits. Earnings per share was 21.31.
Revenue5.91B
Gross Profit2.18B
Operating Income331.57M
Pretax Income446.43M
Net Income284.91M
EBITDA711.80M
Earnings Per Share (EPS)21.31
Cash Flow
In the last 12 months, operating cash flow was 259.60M and capital expenditures 0.00, giving a free cash flow of 259.60M billion.
Operating Cash Flow259.60M
Free Cash Flow259.60M
Free Cash Flow per Share19.42
Dividends & Yields
Venus Remedies Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change2.42%
50-Day Moving Average306.33
200-Day Moving Average330.51
Relative Strength Index (RSI)64.64
Average Volume (3m)3.69K
Important Dates
Venus Remedies Limited upcoming earnings date is May 30, 2025, TBA Not Confirmed.
Last Earnings DateFeb 4, 2025
Next Earnings DateMay 30, 2025
Ex-Dividend DateSep 23, 2013
Financial Position
Venus Remedies Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Venus Remedies Limited has paid 161.53M in taxes.
Income Tax161.53M
Effective Tax Rate―
Enterprise Valuation
Venus Remedies Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Venus Remedies Limited has ₹871.90M in cash and marketable securities with ₹2.98B in debt, giving a net cash position of -₹871.90M billion.
Cash & Marketable Securities₹871.90M
Total Debt₹2.98B
Net Cash-₹871.90M
Net Cash Per Share-₹65.23
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Venus Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―